sPLA2 inhibitor 1结构式
|
常用名 | sPLA2 inhibitor 1 | 英文名 | sPLA2 inhibitor 1 |
---|---|---|---|---|
CAS号 | 393569-31-8 | 分子量 | 487.63 | |
密度 | 1.1±0.1 g/cm3 | 沸点 | 720.9±60.0 °C at 760 mmHg | |
分子式 | C31H37NO4 | 熔点 | N/A | |
MSDS | 美版 | 闪点 | 389.8±32.9 °C |
sPLA2 inhibitor 1用途sPLA2抑制剂1是一种D-酪氨酸衍生物,是一种口服有效的分泌型磷脂酶A2(sPLA2)抑制剂,对人非胰腺分泌型PLA2亚型IIa(HNPPLA2 IIa)的IC50为29 nM。sPLA2抑制剂1具有抗炎活性[1]。 |
中文名 | sPLA2抑制剂 |
---|---|
英文名 | KH064 |
英文别名 | 更多 |
描述 | sPLA2抑制剂1是一种D-酪氨酸衍生物,是一种口服有效的分泌型磷脂酶A2(sPLA2)抑制剂,对人非胰腺分泌型PLA2亚型IIa(HNPPLA2 IIa)的IC50为29 nM。sPLA2抑制剂1具有抗炎活性[1]。 |
---|---|
相关类别 | |
靶点 |
sPLA2:29 nM (IC50) |
体内研究 | sPLA2抑制剂1(化合物2b;口服;5 mg/kg/天;接种关节炎原后第10-13天)显示出对水肿的显著抑制。药物治疗的大鼠表现为轻度囊性水肿和少量巨噬细胞浸润红髓[1]。 |
参考文献 |
密度 | 1.1±0.1 g/cm3 |
---|---|
沸点 | 720.9±60.0 °C at 760 mmHg |
分子式 | C31H37NO4 |
分子量 | 487.63 |
闪点 | 389.8±32.9 °C |
精确质量 | 487.272247 |
LogP | 6.16 |
蒸汽压 | 0.0±2.4 mmHg at 25°C |
折射率 | 1.573 |
储存条件 | 2-8°C |
个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
安全声明 (欧洲) | 22-24/25 |
危险品运输编码 | NONH for all modes of transport |
Inhibitors of secretory phospholipase A2 group IIA.
Curr. Med. Chem. 12(25) , 3011-26, (2005) Phospholipases A2 cleave membrane phospholipids to release arachidonic acid, the precursor to a large family of pro-inflammatory eicosanoids including prostaglandins and leukotrienes that have been pr... |
|
Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A2 in young spontaneously hypertensive rats.
J. Immunol. 176(11) , 7000-7, (2006) The development of fibrosis in the chronically hypertensive heart is associated with infiltration of inflammatory cells and cardiac hypertrophy. In this study, an inhibitor of the proinflammatory enzy... |
|
Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition-mediated cell death in K-ras mutant lung cancer cells.
J. Thorac. Cardiovasc. Surg. 144(6) , 1479-85, (2012) There are currently no targeted therapies against lung tumors with oncogenic K-ras mutations that are found in 25% to -40% of lung cancers and are characterized by their resistance to epidermal growth... |
KH064 |
Benzenepentanoic acid, γ-[(1-oxo-7-phenylheptyl)amino]-4-(phenylmethoxy)-, (γS)- |
MFCD06411576 |
sPLA2 inhibitor |
(4S)-5-[4-(Benzyloxy)phenyl]-4-[(7-phenylheptanoyl)amino]pentanoic acid |
5-(4-Benzyloxyphenyl)-4S-(7-phenylheptanoylamino)pentanoic acid |